Does Rallies show 13F holders for MPLT?

Yes. Rallies tracks hedge fund and 13F ownership data for MPLT, including fund names, share counts, latest tracked quarter, and position changes when available.

Is MPLT research on Rallies investment advice?

No. Rallies provides research, data, and educational context for MPLT. It does not provide personalized investment advice.

MPLT (MapLight Therapeutics, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

MapLight Therapeutics, Inc. Common Stock (MPLT) is a publicly traded the market company. As of May 21, 2026, MPLT trades at $27.81 with a market cap of $1.20B and a P/E ratio of -1.47. MPLT moved +2.99% today. Year to date, MPLT is +61.50%; over the trailing twelve months it is flat. Its 52-week range spans $12.24 to $33.28. Analyst consensus is strong buy with an average price target of $38.26. Rallies surfaces MPLT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns MPLT stock?

Hedge funds tracked by Rallies that own MPLT include Orbimed Advisors. The latest tracked quarter is Dec 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for MapLight Therapeutics, Inc. Common Stock.

MPLT Key Metrics

Key financial metrics for MPLT
Metric	Value
Price	$27.81
Market Cap	$1.20B
P/E Ratio	-1.47
EPS	$-18.56
Dividend Yield	0.00%
52-Week High	$33.28
52-Week Low	$12.24
Volume	0
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-161.15M
Gross Margin	0.00%

Top Hedge Funds Holding MPLT

Orbimed Advisors holds 56.00K shares of MPLT, changed +0.00% as of Dec 31, 2025.

Latest MPLT News

MapLight Completes 307-Patient Schizophrenia and 161-Patient Autism Trials; Q1 Cash $395M — May 14, 2026
MapLight Ends 2025 with $453.1M Cash; ZEPHYR, IRIS Trials Reporting Q3 2026 — Mar 26, 2026

Recent MPLT Insider Trades

Kroeger Christopher A. sold 118.04K (~$3.21M) on May 18, 2026.
Kroeger Christopher A. sold 198 (~$5.57K) on May 18, 2026.
Hanson Kristopher sold 284 (~$7.84K) on May 11, 2026.

MPLT Analyst Consensus

6 analysts cover MPLT: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $38.26.

Common questions about MPLT

Who owns MPLT stock?: Hedge funds tracked by Rallies that own MPLT include Orbimed Advisors. The latest tracked quarter is Dec 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for MapLight Therapeutics, Inc. Common Stock.
Does Rallies show 13F holders for MPLT?: Yes. Rallies tracks hedge fund and 13F ownership data for MPLT, including fund names, share counts, latest tracked quarter, and position changes when available.
Is MPLT research on Rallies investment advice?: No. Rallies provides research, data, and educational context for MPLT. It does not provide personalized investment advice.